Dixon Hughes Goodman Wealth Advisors’s Genmab GMAB Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1K	Buy	+39	New	+$1.34K	﹤0.01%	786

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's GMAB Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors opened a new position in Genmab (GMAB) in Q1 2022: 39 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #786 among its holdings.

204 funds tracked by Wall St. Rank hold GMAB as of Q1 2022.

Dixon Hughes Goodman Wealth Advisors held 39 shares of Genmab worth $1K as of Q1 2022.
Genmab was a new Dixon Hughes Goodman Wealth Advisors position in Q1 2022.
Genmab made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #786 holding.
204 funds tracked by Wall St. Rank held Genmab as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.